Tower Research Capital »

Xtl Biopharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Xtl Biopharmaceuticals (XTLB) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Xtl Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xtl Biopharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xtl Biopharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $587 244 2.41

More positions owned by Tower Research Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Tower Research Capital

Top funds holding Xtl Biopharmaceuticals

Noked Israel
Rhumbline Advisers
GAMMA Investing
Tower Research Capital
Morgan Stanley

View all funds holding Xtl Biopharmaceuticals